A detailed history of Wills Financial Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wills Financial Group, Inc. holds 30,162 shares of MRK stock, worth $3 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
30,162
Previous 29,612 1.86%
Holding current value
$3 Million
Previous $3.67 Million 6.55%
% of portfolio
1.54%
Previous 1.79%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $61,132 - $70,933
550 Added 1.86%
30,162 $3.43 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $611,695 - $656,955
4,941 Added 20.03%
29,612 $3.67 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $262,150 - $305,464
2,315 Added 10.36%
24,671 $3.26 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $1.88 Million - $2.04 Million
18,730 Added 516.55%
22,356 $2.44 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $36,032 - $40,015
350 Added 10.68%
3,626 $373,000
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $337,231 - $376,281
3,276 New
3,276 $348,000
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $667,013 - $774,059
-10,224 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $30,979 - $36,430
-537 Reduced 4.99%
10,224 $725,000
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $523,955 - $615,593
-10,308 Reduced 48.92%
10,761 $653,000
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $48,513 - $56,386
-952 Reduced 4.32%
21,069 $1.15 Million
Q4 2017

Feb 08, 2018

SELL
$51.62 - $61.64 $120,068 - $143,374
-2,326 Reduced 9.55%
22,021 $1.24 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $56,851 - $61,172
-969 Reduced 3.83%
24,347 $1.56 Million
Q2 2017

Aug 10, 2017

BUY
N/A
25,316
25,316 $1.62 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wills Financial Group, Inc. Portfolio

Follow Wills Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wills Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wills Financial Group, Inc. with notifications on news.